82586-60-5 + 82717-96-2 = 82586-55-8 反应条件:1.1 Reagents: Triethylamine,Dicyclohexylcarbodiimide,1-Hydroxybenzotriazole Solvents: Tetrahydrofuran2.1 Reagents: Trifluoroacetic Acid Solvents: Trifluoroacetic Acid 标题:Synthesis Of Novel Angiotensin Converting Enzyme Inhibitor Quinapril And Related Compounds. A Divergence Of Structure-Activity Relationships For Non-Sulfhydryl And Sulfhydryl Types 作者:Klutchko,Sylvester; Et Al 参考文献:Journal Of Medicinal Chemistry 日期:1986 卷标:29(10) 页码:1953-61]
= 82586-55-8 反应条件:1.1 Reagents: Sodium Carbonate Solvents: Dimethylformamide; 10 H,Rt2.1 Reagents: P-Toluenesulfonic Acid Solvents: Toluene; 10 H,Reflux3.1 Reagents: Hydrogen,Hydrochloric Acid Catalysts: Palladium Dihydroxide Solvents: Ethanol,Water; 1 H,60 Psi,Rt 标题:Application Of Ugi Three Component Reaction For The Synthesis Of Quinapril Hydrochloride 作者:Borase,Bhushan B.; Et Al 参考文献:Synthetic Communications 日期:2020 卷标:50(1) 页码:48-55]
= 82586-55-8 反应条件:1.1 Reagents: Hydrogen,Hydrochloric Acid Catalysts: Palladium Dihydroxide Solvents: Ethanol,Water; 1 H,60 Psi,Rt 标题:Application Of Ugi Three Component Reaction For The Synthesis Of Quinapril Hydrochloride 作者:Borase,Bhushan B.; Et Al 参考文献:Synthetic Communications 日期:2020 卷标:50(1) 页码:48-55]
= 82586-55-8 反应条件:1.1 Reagents: Hydrogen,Hydrochloric Acid Catalysts: Palladium Solvents: Diethyl Ether 标题:Methods For The Synthesis Of Aminosuberic Acid Derivatives 参考文献:Germany]
82586-56-9 = 82586-55-8 反应条件:1.1 Reagents: Trifluoroacetic Acid Solvents: Trifluoroacetic Acid 标题:Synthesis Of Novel Angiotensin Converting Enzyme Inhibitor Quinapril And Related Compounds. A Divergence Of Structure-Activity Relationships For Non-Sulfhydryl And Sulfhydryl Types 作者:Klutchko,Sylvester; Et Al 参考文献:Journal Of Medicinal Chemistry 日期:1986 卷标:29(10) 页码:1953-61]
103733-30-8 + 82717-96-2 = 82586-55-8 反应条件:1.1 Reagents: Triethylamine,Dicyclohexylcarbodiimide,1-Hydroxybenzotriazole Solvents: Dichloromethane2.1 Reagents: Hydrogen Catalysts: Palladium Solvents: Tetrahydrofuran 标题:Synthesis Of Novel Angiotensin Converting Enzyme Inhibitor Quinapril And Related Compounds. A Divergence Of Structure-Activity Relationships For Non-Sulfhydryl And Sulfhydryl Types 作者:Klutchko,Sylvester; Et Al 参考文献:Journal Of Medicinal Chemistry 日期:1986 卷标:29(10) 页码:1953-61]
专利号:US-2008287407-A1 优先权日:2003-12-10 标题 :Nitric Oxide Releasing Pyruvate Compounds, Compositions and Methods of Use 发明人:GARVEY DAVID S; FANG XINQIN; KHANAPURE SUBHASH P; RANATUNGA RAMANI R; WEY SHIOW-JYI 权利人:NITROMED INC 摘要:The invention describes novel nitrosated and/or nitrosylated pyruvate compounds and pharmaceutically acceptable salts thereof, and novel compositions comprising at least one nitrosated and/or nitrosylated pyruvate compound, and, optionally, at least one compound that donates, transfers or releases nitric oxide, stimulates endogenous synthesis of nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor or is a substrate for nitric oxide synthase, and/or at least one therapeutic agent. The invention also provides novel compositions comprising at least one pyruvate compound and at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase and/or at least one therapeutic agent. The invention also provides novel kits comprising at least one pyruvate compound, that is optionally nitrosated and/or nitrosylated, and, optionally, at least one nitric oxide donor and/or at least one therapeutic agent. The invention also provides methods for treating diseases resulting from oxidative stress, diabetes, reperfusion injury following ischemia, preservation of tissues, organs, organ parts and/or limbs.
专利号:US-9757463-B2 优先权日:2012-06-15 标题 :Linear polyester and semi-linear glycidol polymer systems: formulation and synthesis of novel monomers and macromolecular structures 发明人:HARTH EVA M; BEEZER DAIN B; LI GUANGZHAO; SPEARS BENJAMIN R; STEVENS DAVID M 权利人:UNIV VANDERBILT 摘要:Disclosed herein are glycidol-based polymers, nanoparticles, and methods related thereto useful for drug delivery. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
专利号:WO-2005105153-A1 优先权日:2004-04-30 标 题 :Hydroxyalkyl derivatives of biologically active compounds 发明人:DESHPANDE JAYANT VENKATESH; KADAM VAISHALI MADHUKAR; GUPTE VANDANA SANDEEP; RANBHAN KAMLESH JAYANTILAL 权利人:KOPRAN RES LAB LTD; DESHPANDE JAYANT VENKATESH; KADAM VAISHALI MADHUKAR; GUPTE VANDANA SANDEEP; RANBHAN KAMLESH JAYANTILAL 摘要:Hydroxyalkyl derivatives of biologically active compounds represented by the formula VII wherein R2 = H, CI-12 alkyl, C6-12 aryl, or -OH and D = Biologically active agent having functional groups such as Formula (a) epoxy or aziridine and Z' = Formula (b) L= spacer comprising (un)substituted alkyl, hydroxyalkyl or alkoxy alkyl with the condition that the carbon chain length contains 2 to 6 carbon atoms when Z' = Formula (c) and pharmaceutically acceptable acid addition salts and enantiomers thereof Also process for the synthesis of compounds of the Formula VII and pharmaceutically acceptable acid addition salts and enantiomers thereof comprising condensation of the biologically active agents having functional groups such as Formula (d) epoxy or azifidine with substituted alkyl derivatives under alkaline conditions, at 20 - 80°C, in an organic solvent.
专利号:CN-111699248-A 优先权日:2018-01-31 标题:Biocatalysts and methods for the synthesis of mixed disulfide conjugates of thienopyridine compounds
专利号:US-8440695-B2 优先权日:2005-11-09 标 题:Use of chloroquine to treat metabolic syndrome 发明人:KASTAN MICHAEL B; SEMENKOVICH CLAY F; SCHNEIDER JOCHEN 权利人:KASTAN MICHAEL B; SEMENKOVICH CLAY F; SCHNEIDER JOCHEN; ST JUDE CHILDRENS RES HOSPITAL; UNIV WASHINGTON 摘要:The present invention provides methods and compositions for modulating certain metabolic processes and for treating a variety of disorders associated with metabolic syndrome, including insulin related disorders, ischemia, oxidative stress, atherosclerosis, hypertension, obesity, abnormal lipid metabolism, and stroke by administering an effective dose of a chloroquine compound. The invention also provides methods and compositions relating to administering an effective dose of a chloroquine compound in combination with at least a second pharmaceutically active ingredient or compound including an antihyperglycemic diabetes treatment, an antihypertensive agent, an antithrombotic agent, and/or an inhibitor of cholesterol synthesis or absorption.
专利号:CN-108191758-A 优先权日:2018-01-08 标题:A kind of intermediate used in the synthesis of angiotensin-converting enzyme inhibitors and its preparation method
1: Stolarczyk M, Maślanka A, Apola A, Krzek J. Determination of losartan potassium, quinapril hydrochloride and hydrochlorothiazide in pharmaceutical preparations using derivative spectrophotometry and chromatographic-densitometric method. Acta Pol Pharm. 2013 Nov-Dec;70(6):967-76. doi: 10.1002/jps.22387. Epub 2010 Nov 24. doi: 10.1002/jps.22051. doi: 10.1002/jps.21767. doi: 10.4103/0250-474X.44612. 13: Stanisz B. The influence of pharmaceutical excipients on quinapril hydrochloride stability. Acta Pol Pharm. 2005 May-Jun;62(3):189-93. Review.
合成参考文献
摘要:Iyakuhin Kenkyu. Study of Medical Supplies., 26(740), 1995 摘要:Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC105623